A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age45+
SponsorNanfang Hospital, Southern Medical University
About this trial
The goal of this is to learn about the effectiveness and feasibility of a novel AI- assisted Mobile Capsule Gastroscopy (MCG) system for detecting gastric pathologies in elderly and high-risk populations.
The main question it aims to answer is:
Can MCG effectively detect gastric pathologies, including common gastric diseases, gastric cancer, and precancerous lesions, in elderly and high-risk individuals at community health centers?
Participants will:
Epidemiological, diagnostic, and post-MCG follow-up data generated during participants' involvement in the gastric pathologies public screening program will be collected.
Eligibility criteria
Qualifiers
Elderly cohort: Permanent residents of Guangzhou aged ≥60 years who have not undergone specialized gastric disease screening in the past three years;
History of Helicobacter pylori infection (positive ¹³C/¹⁴C urea breath test);
Prior diagnosis of chronic atrophic gastritis, gastric ulcer, neoplastic gastric polyps, hypertrophic gastritis, or pernicious anemia;
Family history of gastric cancer (first-degree relative with a confirmed diagnosis);
Disqualifiers
Not considered by the investigator to be suitable for participation in this study.
Trial design
Treatments tested in this trial
- Collect epidemiological, diagnostic, and follow-up data after MCG examination.
Treatment groups
10,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Nanfang Hospital, Southern Medical University
Lead sponsor
Guangzhou First People's Hospital
Collaborator
Second Affiliated Hospital of Guangzhou Medical University
Collaborator
Guangdong Provincial Hospital of Traditional Chinese Medicine
Collaborator
Source ClinicalTrials.gov